Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Endocrine 2NET 1

Conditions

Neuroendocrine Tumors 3Pheochromocytoma 1Paraganglioma 1Neuroblastoma 1Neural crest tumor 1

Interventions

gallium Ga 68 dotatate 4fluorodopa F 18 2Magnetic Resonance Spectroscopy 2pertuzumab 1pentetreotide 1olaparib 1lutetium Lu 177 dotatate 1arginyllysine 1Whole Body Imaging 1Tretinoin 1Nivolumab 1Isotretinoin 1Furosemide 1Erlotinib Hydrochloride 1Amino Acids 190Y-octreotide, DOTA-Tyr(3)- 14-chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid 13-fluorobenzylguanidine 1(18F)GTP1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × 3-fluorobenzylguanidine × NET × Clear all
NCT05069220 2024-03-01

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Recruiting
150 enrolled
CNSEndocrineNET

Neuroblastoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡